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Abstract 
The present study was designed to assess the antimicrobial activity of 19 natural products belonging to terpenoids, 
alkaloids, thiophenes and phenolics against a panel of 14 Gram-negative multidrug-resistant (MDR) bacteria. The 
results demonstrated that amongst the studied compounds, alkaloids and terpenoids were less active contrary to 
flavonoids: neocyclomorusin (3) and candidone (6) and isoflavonoids: neobavaisoflavone (8) and daidzein (12). 
Thiophene, 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17) showed moderate and selective activities. 
Compounds 3, 6, 8 and 12 displayed minimal inhibitory concentration (MIC) ranged from 4 to 256 μg/mL on all the 
14 tested bacteria. MIC values below 10 μg/mL were obtained with 8, 3, 6 and 12 against 50, 42.9, 35.7 and 21.4 % of 
the tested bacteria. The lowest MIC value of 4 μg/mL was obtained with compound 3 against Klebsiella pneumoniae 
ATCC11296, Enterobacter cloacae BM47, compound 6 against Escherichia coli ATCC8739, K. pneumoniae ATCC11296, 
E. cloacae BM47 and compound 8 against K. pneumoniae ATCC11296 and E. cloacae BM47. The activity of flavonoid 3 
was better or equal to that of chloramphenicol in all tested K. pneumoniae, Providencia stuartii, E. aerogenes, E. cloacae 
and Pseudomonas aeruginosa strains. Within isoflavonoids, neobavaisoflavone scaffold was detected as a pharma-
cophoric moiety. This study indicates that natural products such as 3, 6 and 8 could be explored more to develop 
antimicrobial drugs to fight MDR bacterial infections.
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Background
Infectious diseases including bacterial infections con-
tinue to be a serious health problem worldwide. Multid-
rug-resistant (MDR) pathogens considerably increase the 
mortality and morbidity. In effect, clinically, the continu-
ous emergence of Gram-negative MDR bacteria drastically 
reduced the efficacy of antibiotic arsenal leading globally 
to an increase of the frequency of therapeutic failure (Rice 
2006). Consequently, new antibacterials are needed to 
fight these bacterial pathogens, but progress in developing 
them have been slow (Fischbach and Walsh 2009). Plant 
kingdom represents an enormous source of new chemo-
therapeutic agents to tackle microbial infections. Several 
natural compounds belonging to the usual pharmaceutical 
library have been tested for their ability to combat resist-
ant bacteria (Fischbach and Walsh 2009; Saleem et  al. 
2010). More than 450 natural metabolites with antimicro-
bial activity have been reported in the period 2000–2010 
(Saleem et  al. 2010). Some of the best plant metabolites 
from African medicinal plants with antibacterial activ-
ity against MDR Gram-negative phenotypes include lau-
rentixanthone B (xanthone), diospyrone and plumbagin 
(naphthoquinone), isobavachalcone and 4-hydroxylon-
chocarpin (flavonoids) and MAB3 (coumarin) (Kuete et al. 
2010, 2011a). The rationale of this work comes to the fact 
that secondary metabolites belonging to terpenoids, phe-
nolics and alkaloids previously displayed prominent anti-
bacterial activity against MDR Gram-negative bacteria 
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expressing active efflux pumps (Kuete et al. 2010, 2011a). 
Therefore, the present study was designed to determine 
the antibacterial activity of several molecules, including 
terpenoids, alkaloids, thiophenes and phenolics, against 
different bacterial strains expressing MDR phenotypes. 
Furthermore, we highlighted the possible pharmacophoric 
cores amongst the active compounds.
Results
Studied compounds
Compounds tested in the present study (Fig.  1) were 
previously or newly isolated from several Cameroonian 
plants. They include atalantoflavone (1; yellow solid; 
m.p. 286.2–287.7  °C) (Ouete et  al. 2013); 2′-hydroxy-
atalantoflavone (2; reddish gum) (Ouete et  al. 2013); 
neocyclomorusin (3; yellow solid, m.p. 263.2–266.7 °C) 
(Ouete et al. 2013; Cho et al. 2011); 2-(3,5-dihydroxy-
phenyl)benzofuran-5,6-diol (4; yellow oil) (Ouete et al. 
2014; Noguchi et  al. 1994); 4-hydroxy-2,6-di-(3′,4′-
dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (5; 
yellow solid; m.p. 168.5–169.9  °C) (Kuete et al. 2013); 
candidone (6; yellowish powder; m.p. 95.1–96.2  °C) 
(Ouete et  al. 2013; Kuete et  al. 2013); isoneorautenol 
(7; yellowish solid; m.p. 156.2–157.8  °C) (Nkeng-
fack et  al. 1995; Kuete et  al. 2014); neobavaisoflavone 
(8; yellowish oil) (Nkengfack et  al. 1994; Kuete et  al. 
2014); tecleaverdoornine (9; amorphous solid) (Aya-
for and Okogun 1982; Sandjo et  al. 2014); maculine 
(10; amorphous solid) (Nunes et al. 2005; Kuete et al. 
2008b; Sandjo et al. 2014); deacetylnomilin (11; color-
less oil) (Bennett and Hasegawa 1981); daidzein (12; 
yellowish gum) (Basha et  al. 2013); isowighteone (13; 
yellowish gum) (Wang et  al. 2001); dorstenin (14; 
white solid; m.p. 136–139 °C) (Kuster et al. 1994; Abe-
gaz et  al. 2004); herranone (15; colorless solid; m.p. 
285–287 °C) (Wiedemann et al. 1999); isogarcinol (16; 
brown oil) (Marti et  al. 2010); 2-(penta-1,3-diynyl)-5-
(3,4-dihydroxybut-1-ynyl)thiophene (17; brownish oil) 
(Shi et  al. 2010); ulmoside A (18; brown oil) (Rawat 
et  al. 2009) and 3,4,3′-tri-O-methylellagic acid (19; 
brown solid; m.p. 282–284 °C) (Gao et al. 2014). These 
compounds belong to flavonoids (1-3, 6, 18), isoflavo-
noids (7, 8, 12, 13), benzophenone (16), benzofuran 
(4), ellagic acid derivative (19), lignan (5), alkaloids 
(9, 10), terpenoids (11, 15) and thiophene (19). They 
were tested for their antimicrobial activity on a panel 
of 14 bacterial strains and the results are summarized 
in Table 1.
Activity of terpenoids
Both diterpenoid (11) and triterpenoid (15) exhibited 
very weak activities. Deacetylnomilin (11) and herranone 
(15) had detectable MIC values against 2/14 (14.3  %) 
and 5/14 (35.7 %) bacterial strains respectively (Table 1). 
However, no minimal bactericidal concentration (MBC) 
value was obtained with the two terpenoids.
Activity of alkaloids
Furoquinoline alkaloids tecleaverdoornine (9) and macu-
line (10) displayed low activity against the tested bacte-
ria. Their inhibitory effects were observed on 1/14 (7.1 %) 




but-1-ynyl)thiophene (17) showed MIC values below 
100  µg/mL against Escherichia coli ATCC 8739, Entero-
bacter aerogenes ATCC 13048 and EA27, Klebsiella 
pneumoniae ATCC11296 and Providencia stuartii 
ATCC29916 (Table 1).
Activity of phenolics (flavonoids, isoflavonoids, 
benzophenone, benzofuran, coumarins, ellagic acid 
derrivative and lignan)
The best activities were obtained with phenolic com-
pounds; amongst them, flavonoids neocyclomorusin (3) 
and candidone (6) as well as isoflavonoids neobavaisofla-
vone (8) and daidzein (12) had MIC values ranged from 4 
to 256 µg/mL on all the 14 tested bacteria. Moreover, MIC 
values below 10 µg/mL were obtained with 8, 3, 6 and 12 
against 7/14 (50 %), 6/14 (42.9 %), 5/14 (35.7 %) and 3/14 
(21.4  %) tested bacteria respectively. MIC values below 
100 µg/mL were obtained with compound 3 on all tested 
bacteria. MBC values below 10 µg/mL were also obtained 
with compound 3 against K. pneumoniae ATCC11296 
and Enterobacter cloacae BM47 whilst values ranged from 
8 to 256 µg/mL were noted on all tested pathogens. The 
lowest MIC value of 4  µg/mL was obtained with com-
pound 3 against K. pneumoniae ATCC11296, E. cloacae 
BM47, compound 6 against E. coli ATCC8739, K. pneu-
moniae ATCC11296, E. cloacae BM47 and compound 8 
against K. pneumoniae ATCC11296 and E. cloacae BM47.
Structure–activity relationship study
When analyzing the structure–activity relationship, it 
can be observed that terpenoids (both diterpenoids and 
triterpenoids) as well as the tested furoquinoline alka-
loids were poor antimicrobial compounds. A keen look 
of the activities of phenolics shows that benzophenone 
(16) were not active meanwhile coumarin (14), lignan (5) 
and benzofuran (4) were also found to be poor antibacte-
rial agents. The best activities were obtained with flavo-
noids and isoflavonoids. Within flavonoids, it appeared 
that hydroxylation of compound 1 to yield 2 did not 
significantly changed the antibacterial activity (Table 1). 



































































































Fig. 1 Chemical structures of tested compounds. Atalantoflavone (1); 2′-hydroxyatalantoflavone (2); neocyclomorusin (3); 2-(3,5-dihydroxyphenyl)
benzofuran-5,6-diol (4); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (5); Candidone (6); isoneorautenol (7); neobavaiso-
flavone (8); tecleaverdoornine (9); maculine (10); deacetylnomilin (11); daidzein (12); isowighteone (13); dorstenin (14); herranone (15); 2-(penta-
1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17); isogarcinol (16); ulmoside A (18) and 3,4,3′-tri-O-methylellagic acid (19)
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The presence of a cyclic prenyl moiety in the heterocyclic 
portion of flavone 3 improves significantly the activity 
and provides a large antimicrobial selectivity. Regardless 
the presence of the α,β-unsaturated double bond, com-
pound 6 showed interesting activity like 3. Compound 6 
differs from 1 to 3 with the α,β-unsaturated double bond 
and its high lipophilicity turning this latter along with 3 
as two pharmacophores to be explored for antimicro-
bial chemotherapy. Nevertheless, the high hydrophilic-
ity of compound 18 reduced drastically its antimicrobial 
potency (Fig. 2). Concerning the activity of isoflavonoid, 
it also appeared that neobavaisoflavone (8) was another 
pharmacophoric moiety (Fig. 3). Any modification of the 
structure of compound 8 such as cyclisation or absence 
of prenyl group resulted in the reduction of antibacterial 
activity as it can be seen with compounds 7, 12 and 13.
Discussion
Bacterial multidrug resistance represents a major 
hurdle in the treatment of infectious diseases. In the 
present study, we tested a panel of bacterial strains 
including both reference ATCC strains and MDR phe-
notypes expressing active efflux pumps (Kuete et  al. 
2010, 2011a; Fankam et  al. 2011). In fact, tripartite 
drug efflux pumps, mainly those clinically reported as 
AcrAB–TolC in Enterobacteriaceae or as MexAB–OprM 
in Pseudomonas aeruginosa tested in the present study, 
play a key role in multidrug resistance of pathogenic 
Gram-negative bacteria (Nikaido 2009; Davin-Regli 
et al. 2008). Interestingly, a MIC value of 64 µg/mL was 
recorded with the best compounds (namely flavonoid 3 
and isoflavonoid 8) against the problematic MDR strain 
P. aeruginosa PA124. This value was identical to that of 
the reference compound chloramphenicol (Table  1). 
The antimicrobial activity of a phytochemical has been 
defined as significant when MIC is below 10  µg/mL, 
moderate when 10  µg/mL  <  MIC  <  100  µg/mL or low 
when MIC > 100 µg/mL (Kuete 2010; Kuete and Efferth 
2010). In the present study, MIC values below 10 µg/mL 
were noted with compounds 3, 6 and 8 against several 
bacterial strains, highlighting their possible use in the 
control of bacterial infections. The activity of flavonoid 
3 was better or equal to that of chloramphenicol in the 
majority of the bacteria including all tested K. pneumo-
niae, P. stuartii, E. aerogenes, E. cloacae and P. aeruginosa 
strains (Table 1). This was also the case with compounds 
6 and 8 towards the majority of the tested bacterial 
strains and mostly the MDR phenotypes. Regarding the 
involvement of MDR bacteria in treatment failures and 
the re-emergence of infectious diseases (Blot et al. 2007; 
Falagas and Bliziotis 2007; Nicolle 2001), the activity of 
flavonoids 3, 6 and isoflavonoid 8 could be considered 
very promising. Pseudomonas aeruginosa is an impor-
tant nosocomial pathogen highly resistant to clinically 
used antibiotics, causing a wide spectrum of infections 




























open form of the prenyl and 
increase of lipophylicity 
improve the activity
one more cyclized prenyl 
group improves the activity
one more OH does 
not change the activity
Lack of the prenyl group and 
the high hydroplilicity 
decrease the activity
Lack of the prenyl group and 






Fig. 2 Pharmacophores (3 and 6) detected in flavonoids
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(Cardoso et  al. 2007) and was found sensitive to the 
three compounds (3, 6 and 8). MDR Enterobacteriaceae, 
including K. pneumoniae, E. aerogenes, P. stuartii and E. 
coli, have also been classified as antimicrobial-resistant 
organisms of concern in healthcare facilities (Nicolle 
2001; Tran et  al. 2010). The analysis of data of Table  1 
shows that MBC/MIC ratios below 4 were recorded with 
the three best compounds (3, 6 and 8) in many cases, 
suggesting that bacterial effects of these phytochemi-
cals could be expected (Mims et al. 1993; Mbaveng et al. 
2011, 2012). The data reported herein highlight once 
more the good pharmacological potential of flavonoids 
3, 6 and isoflavonoid 8 and their ability to combat infec-
tions involving these bacterial species. Furthermore, the 
pharmacophoric moiety (8) suggests that hemi-synthe-
sis reaction with neobavaisoflavone could be explored 
in more details for antibacterial drug development. To 
the best of our knowledge, the antibacterial activity of 
the best compounds (3, 6 and 8) against MDR bacte-
ria is being reported for the first time. However, several 
flavonoids and isoflavonoids are known to possess anti-
bacterial activities against both drug-sensitive and MDR 
Gram-negative phenotypes (Kuete et  al. 2010, 2011a; 
Ndhlala et al. 2013; Ngameni et al. 2013).
Methods
General procedure
Column chromatography (CC) and thin layer chroma-
tography (TLC) were performed over silica gel 60H 
(particle size 90  %  <45  mm), 200–300 mesh silica gel 
silica gel GF254, respectively. 1D- and 2D-NMR spec-
tra were carried out with a Bruker DRX-400  MHz. 
Melting points were measured by an Electro ther-
mal IA 9000 digital melting point apparatus and are 
uncorrected.
Plant material
Plant species were collected in Yaoundé (Centre Region, 
Cameroon) and in Dschang (West Region, Cameroon) 
and identified by the specialist of the national herbar-
ium in Yaoundé, Cameroon where their voucher are 
kept under the registration codes: Teclea afzelii Engl. 
(Rutaceae) (10674/SRF/Cam), Erythrina excelsa Baker 
(Fabaceae) (61487/HNC), Erythrina senegalensis A. Rich. 
(Fabaceae) (59409/HNC), Echinops giganteus A. Rich. 
(Asteraceae) (23647/SRF-Cam), Pachystela msolo Engl. 
(Sapotaceae) (3849/SRFK), Garcinia ovalifolia Oliv. (Gut-
tiferae) (55523/HNC) and Alchornea laxiflora (Benth) 


























Absence of the prenyl group
decreases the activity
Cyclisation form of the prenyl
group decreases the activity
Double cyclisation and loss of 
the α,β-unsaturated ketone
group decreases the activity
8
Fig. 3 Representation of pharmacophoric scaffold detected in isoflavonoids
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Ethics statement
For the collection of plants, no specific permits were 
required for the described field studies. For any location/
activity, no specific permissions were required. All loca-
tions where the plants were collected were not privately-
owned or protected in any way and the field studies did 
not involved endangered or protected species.
Extraction and isolation
Compounds tested in the present work were either previ-
ously isolated in our research team (1–10, 14) or newly 
isolated (12, 13, 15–19). Compounds 1–3 were obtained 
from the roots of Milicia excelsa whilst 4 was identified 
from the leaves as previously reported (Ouete et al. 2013, 
2014). Compounds 5 and 6 were isolated from Echinops 
giganteus (Asteraceae) (Kuete et  al. 2013), while 7 and 
8 were obtained from Erythrina sigmoidea (Fabaceae) 
(Kuete et  al. 2014). Compounds 9 and 10 were isolated 
from Zanthoxylum buesgenii (Rutaceae) (Sandjo et  al. 
2014). Compound 14 was isolated from Dorstenia ellip-
tica (Moraceae) (Abegaz et al. 2004).
Compound 11 in addition to 9 and 10 were isolated 
from the roots of Teclea afzelii (Rutaceae); Hence, air-
dried roots (7 kg) were macerated in MeOH/DCM (1:1, 
v/v) for 48  h and the organic (286  g) solid obtained 
after evaporation of the solvents in vacuo was further 
extracted with hexane (hex, 41 g), ethyl acetate (EA, 44 g) 
and MeOH (201 g). The EA fraction was purified by col-
umn chromatography on silica gel in gradient conditions 
of hex/EA. Three compounds were isolated as follows: 9 
(6 mg), 10 (5 mg) and 11 (10 mg).
Compound 12 was obtained from the roots of Eryth-
rina excelsa (2.2  kg) (Fabaceae); The crude extract 
obtained from the maceration of the air-dried roots was 
fractioned by silica gel flash chromatography using hex/
EA in gradient conditions. The fraction issued from hex/
EA (1:1) was chromatographed using the same condition 
as above from which 12 (45 mg) was isolated. Similarly, 
13 (5 mg) was isolated from the roots of Erythrina sen-
egalensis (Fabaceae) as described for 12. Compound 17 
(5.0  mg) was isolated from the roots of Echinops gigan-
teus; the powdered roots of E. giganteus (Asteraceae) 
was macerated successively in DCM/MeOH (1:1, v/v) 
and MeOH for 48 h and 24 h, respectively. The organic 
solutions were pooled together based on their TLC pro-
file. Eighty-one grams of a red dark crude extract were 
obtained after evaporation in vacuo. Furthermore, the 
crude extract was poured onto water and extracted with 
Hex (A, 10 g), DCM (B, 25 g), EA (C, 30 g), n-butanol (D, 
5 g). Fraction B was purified on silica gel CC using gra-
dient conditions of Hex/EA and 17 was obtained from 
the Hex/EA (3:2, v/v). Similarly, bark powder (2.8 kg) of 
Pachystela msolo Engl. (Sapotaceae) was extracted with 
DCM/MeOH (1:1), yielding a dark crude extract (30 g). 
The purification of this later in gradient conditions of 
Hex/EA afforded 15 (5  mg). The stem bark (2.5  kg) of 
Garcinia ovalifolia (Guttiferaceae) was air-dried, ground 
and macerated in MeOH for 48  h. A brown residue 
(120 g) was obtained after concentrating the organic solu-
tion. Vacuum liquid chromatography was used for a first 
fractionation with gradient of hex/EA and EA/MeOH. 
Fractions obtained from Hex and Hex/EA (3:1, v/v) were 
pooled together (1.22  g) and purified by silica gel CC 
with gradients of the same mixture of solvents to afford 
16 (12 mg). Fractions collected from EA/MeOH (9:1 and 
4:1) were also pooled together and purified on silica gel 
CC with gradients of DCM/MeOH to yield compound 
18 (90 mg). The stem bark (1.8 kg) of Alchornea Laxiflora 
(Euphorbiaceae) was macerated in MeOH. The concen-
trated methanol crude extract (30  g) was subjected to 
silica gel flash chromatography using Hex (A), EA (B) 
and MeOH (C). Fraction C (10 g) was purified by silica 
gel CC using the gradient of DCM/MeOH. Compound 




Chloramphenicol  ≥98  % (Sigma-Aldrich, St. Quentin 
Fallavier, France) was used as reference antibiotics (RA) 
against Gram-negative bacteria. p-Iodonitrotetrazolium 
chloride ≥97 % (INT, Sigma-Aldrich) was used as micro-
bial growth indicator (Eloff 1998; Mativandlela et  al. 
2006).
Microbial strains and culture media
The studied microorganisms included sensitive and 
resistant strains of P. aeruginosa, K. pneumoniae, E. aero-
genes, E. cloacae, E. coli, P. stuartii, obtained from the 
American Type Culture Collection. Their bacterial fea-
tures were previously reported (Kuete et al. 2011a; Lac-
mata et al. 2012; Seukep et al. 2013; Touani et al. 2014). 
Nutrient agar were used for the activation of the tested 
Gram-negative bacteria (Kuete et al. 2011b).
INT colorimetric assay for MIC and MBC determinations
The minimal inhibitory concentration (MIC) determina-
tions on the tested bacteria were conducted using rapid 
p-iodonitrotetrazolium chloride (INT) colorimetric assay 
according to described methods (Eloff 1998) with some 
modifications (Kuete et al. 2008b, 2009). The test samples 
and RA were first of all dissolved in DMSO/Mueller–
Hinton Broth (MHB). The final concentration of DMSO 
was lower than 2.5  % and does not affect the microbial 
growth (Kuete et al. 2007, 2008a). The solution obtained 
was then added to Mueller–Hinton Broth, and serially 
Page 8 of 9Mbaveng et al. SpringerPlus  (2015) 4:823 
diluted two fold (in a 96-wells microplate). One hundred 
microlitre (100 µL) of inoculum 1.5 × 106 CFU/mL pre-
pared in appropriate broth was then added (Kuete et al. 
2008b, 2009). The plates were covered with a sterile plate 
sealer, then agitated to mix the contents of the wells using 
a plate shaker and incubated at 37 °C for 18 h. The assay 
was repeated thrice. Wells containing adequate broth, 
100 µL of inoculum and DMSO to a final concentration 
of 2.5 % served as negative control. The MIC of samples 
was detected after 18  h incubation at 37  °C, following 
addition (40 µL) of 0.2  mg/mL of INT and incubation 
at 37  °C for 30  min. Viable bacteria reduced the yellow 
dye to a pink. MIC was defined as the sample concentra-
tion that prevented the color change of the medium and 
exhibited complete inhibition of microbial growth (Eloff 
1998). The minimal bactericidal concentration (MBC) 
was determined by adding 50 µL aliquots of the prepa-
rations, which did not show any growth after incubation 
during MIC assays, to 150 µL of adequate broth. These 
preparations were incubated at 37 °C for 48 h. The MBC 
was regarded as the lowest concentration of extract, 
which did not produce a color change after addition of 
INT as mentioned above (Kuete et al. 2008b, 2009).
Conclusion
Regarding the medical importance of the studied micro-
organisms, the results obtained and reported in this study 
interestingly showed how secondary metabolites are still 
a strong source of inspiration in drug discovery. Thus, 
the present data provided evidence that neocyclomoru-
sin (3), candidone (6) and neobavaisoflavone (8) could 
be potential antimicrobial drugs to fight MDR bacterial 
infections and could also be used as motifs for developing 
related antibiotics with strong potency. To explore more 
the therapeutic values of the studied compounds, a com-
bination with commonly used antibiotics will be further 
performed. Also, the study of the mechanism of action 
of the effective compounds will be carried out to better 
understand their inhibitory effects.
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